Subscribe to RSS
DOI: 10.1055/s-0034-1370356
π-Shaped Lymphaticovenular Anastomosis: The Venous Flow Sparing Technique for the Treatment of Peripheral Lymphedema
Publication History
16 September 2013
15 December 2013
Publication Date:
28 March 2014 (online)
Abstract
Background Nowadays, lymphaticovenular anastomosis has been recognized as an efficient microsurgical treatment for peripheral lymphedema. The technique based on two end-to-side anastomosis is named π-shaped lymphaticovenular anastomosis. This is the venous flow-sparing technique, in which the distal endothelial cells are not sacrificed. The purpose of this study is to evaluate the clinical results of π-shaped lymphaticovenular anastomosis in chronic lymphedema of the upper and lower limbs.
Patients and Methods From November 2010 to August 2011, 20 patients with a peripheral lymphedema were treated by π-shaped lymphaticovenular anastomosis. A total of 12 patients had a lymphedema of the upper limb and 8 patients had a lymphedema of the lower limb. The mean age of the patients was 57.2 years (range, 44–78 years). The mean duration of lymphedema was 6.2 years (range, 1–23 years). The Campisi clinical stage range 2 to 5 (average, 3.3). Every patient was operated under local anesthesia. Four π-shaped lymphaticovenular anastomoses were performed per limb.
Results The mean caliber of lymphatic vessels used for lymphaticovenular anastomosis was 0.55 mm (range, 0.3–0.8 mm). The mean caliber of subdermal venules was 1.2 mm (range, 0.5–2.1 mm).The average operative time to perform one π-shaped lymphaticovenular anastomosis was 55 minutes (range, 45–65 minutes). A venous backflow was found in 98 lymphaticovenular anastomosis (55.7%). Total 16 patients (80%) had a clinically significant circumferential reduction after surgery. The average volume differential reduction rate was 22.9% (range, 4.9–46.3) (p < 0.001).
Conclusions π-Shaped lymphaticovenular anastomosis is a supermicrosurgical method with a low morbidity to treat peripheral lymphedema. The procedure can easily be performed under local anesthesia, and the postoperative recovery is short. The results of this series demonstrate a clinical efficiency of the technique to reduce chronic lymphedema of the limbs.
EBM level IV.
-
References
- 1 Penha TR, Ijsbrandy C, Hendrix NA , et al. Microsurgical techniques for the treatment of breast cancer-related lymphedema: a systematic review. J Reconstr Microsurg 2013; 29 (2) 99-106
- 2 Koshima I, Kawada S, Moriguchi T, Kajiwara Y. Ultrastructural observations of lymphatic vessels in lymphedema in human extremities. Plast Reconstr Surg 1996; 97 (2) 397-405 , discussion 406–407
- 3 Starling EH. On the absorption of fluids from the connective tissue spaces. J Physiol 1896; 19 (4) 312-326
- 4 Sabin FR. On the origin of the lymphatic system from the veins and the development of the lymph hearts and thoracic duct in the pig. Am J Anat 1902; 1: 367-391
- 5 Wigle JT, Harvey N, Detmar M , et al. An essential role for Prox1 in the induction of the lymphatic endothelial cell phenotype. EMBO J 2002; 21 (7) 1505-1513
- 6 Joukov V, Pajusola K, Kaipainen A , et al. A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases. EMBO J 1996; 15 (2) 290-298
- 7 Jussila L, Alitalo K. Vascular growth factors and lymphangiogenesis. Physiol Rev 2002; 82 (3) 673-700
- 8 Zuther JE. Anatomy. In Zuther JE, , ed. Lymphedema Management. 2nd ed. Stuttgart: Thieme Verlag; 2009: 1-28
- 9 Yamada Y. Studies on lymphatic venous anastomosis in lymphedema. Nagoya J Med Sci 1969; 32: 1-21
- 10 O'Brien BM, Sykes P, Threlfall GN, Browning FS. Microlymphaticovenous anastomoses for obstructive lymphedema. Plast Reconstr Surg 1977; 60 (2) 197-211
- 11 O'Brien BM, Shafiroff BB. Microlymphaticovenous and resectional surgery in obstructive lymphedema. World J Surg 1979; 3 (1) 3-15 , 121–123
- 12 O'Brien BM, Mellow CG, Khazanchi RK, Dvir E, Kumar V, Pederson WC. Long-term results after microlymphaticovenous anastomoses for the treatment of obstructive lymphedema. Plast Reconstr Surg 1990; 85 (4) 562-572
- 13 Koshima I, Inagawa K, Urushibara K, Moriguchi T. Supermicrosurgical lymphaticovenular anastomosis for the treatment of lymphedema in the upper extremities. J Reconstr Microsurg 2000; 16 (6) 437-442
- 14 Koshima I, Nanba Y, Tsutsui T, Takahashi Y, Itoh S. Long-term follow-up after lymphaticovenular anastomosis for lymphedema in the leg. J Reconstr Microsurg 2003; 19 (4) 209-215
- 15 Baumeister RG, Siuda S. Treatment of lymphedemas by microsurgical lymphatic grafting: what is proved?. Plast Reconstr Surg 1990; 85 (1) 64-74 , discussion 75–76
- 16 Nagase T, Gonda K, Inoue K , et al. Treatment of lymphedema with lymphaticovenular anastomoses. Int J Clin Oncol 2005; 10 (5) 304-310
- 17 Narushima M, Mihara M, Yamamoto Y, Iida T, Koshima I, Mundinger GS. The intravascular stenting method for treatment of extremity lymphedema with multiconfiguration lymphaticovenous anastomoses. Plast Reconstr Surg 2010; 125 (3) 935-943
- 18 Yamamoto T, Narushima M, Kikuchi K , et al. Lambda-shaped anastomosis with intravascular stenting method for safe and effective lymphaticovenular anastomosis. Plast Reconstr Surg 2011; 127 (5) 1987-1992
- 19 Lasso JM, Perez Cano R. Practical solutions for lymphaticovenous anastomosis. J Reconstr Microsurg 2013; 29 (1) 1-4
- 20 Chang DW. Lymphaticovenular bypass for lymphedema management in breast cancer patients: a prospective study. Plast Reconstr Surg 2010; 126 (3) 752-758